Clinical Trial Update: Neo-adjuvant Abiraterone Prostate Study [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating abiraterone in high-risk localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zytiga (abiraterone acetate)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: High Risk Localised Prostate Carcinoma | Phase 2 | Status: COMPLETED